Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (8)

2022

  1. Dalbavancin in clinical practice in Spain: A 2 year retrospective study

    JAC-Antimicrobial Resistance, Vol. 4, Núm. 6

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. DALBACEN cohort: Dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

    Annals of Clinical Microbiology and Antimicrobials, Vol. 18, Núm. 1

  2. The crisis of antibiotics: From empirical to directed prescription

    Enfermedades Infecciosas y Microbiologia Clinica

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

2015

  1. The Efficacy and Safety of Maraviroc Addition to a Stable Antiretroviral Regimen in Subjects with Suppressed Plasma HIV-RNA is Not Influenced by Age

    AIDS Research and Human Retroviruses, Vol. 31, Núm. 9, pp. 893-897

2013

  1. [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26 Suppl 1, pp. 1-84

2004

  1. Intolerancia a la hidroxicloroquina comercializada en España (Dolquine®) en pacientes con patología autoinmune

    Revista Clinica Espanola, Vol. 204, Núm. 11, pp. 588-591